Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, 250012, China
NCT Number: NCT01896310
The aim of the present study was to propose a new pCLE classification of gastric pit patterns and vessel architecture, and to assess the accuracy and interobserver agreement of this new pCLE classification system in the stomach.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Jinan, Shandong, 250012, China
Probe-based confocal laser endomicroscopy (pCLE; Cellvizio, Mauna Kea Technologies, Paris, France) is a newly developed endoscopic device which allows the application of laser microscopy with any conventional endoscope and mosaic imaging. Previous studies have demonstrated its application in various GI diseases, including Barrett's esophagus, colonic adenoma, ulcerative colitis, and etc. However, limited data are provided on exploring the application of pCLE in the stomach. Therefore, the aim of the present study was to propose a new pCLE classification of gastric pit patterns and vessel architecture, and to assess the accuracy and interobserver agreement of this new pCLE classification system in the stomach.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
all patients will receive pCLE examination
Time frame: 3 month
Patients will be prospectively recruited to evaluate the diagnostic sensitivity, specificity and accuracy of the new classification of gastric pit patterns and vessel architecture using probe-based confocal laser endomicroscopy
Shandong University
Other
New Classification of Gastric Pit Patterns and Vessel Architecture Using Probe-based Confocal Laser Endomicroscopy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02332213
Adenoma, Atrophic Gastritis
Riga, Latvia
View Trial DetailsNCT04840056
Atrophic Gastritis, Digestive System Diseases
Shatin, New Territories, Hong Kong
View Trial DetailsNCT04613570
Atrophic Gastritis, Digestive System Diseases
Porto, Portugal
View Trial DetailsNCT06316882
Atrophic Gastritis, Digestive System Diseases
Portalegre, Portalegre District, Portugal
View Trial Details